Furthermore, it has recently been shown that HSF1 can indirectly influence the resistance of colon cancer cells to oxaliplatin through the activation of protective autophagy and control the expression of multidrug resistance genes [4, 5]. Here, HSF1 is linked to colonic neoplasm.